| Randy Michael Williams, OD | |
|
581 Second St, Manchester, NH 03102-5200 | |
| (603) 668-2010 | |
| (603) 668-3944 |
| Full Name | Randy Michael Williams |
|---|---|
| Gender | Male |
| Speciality | Optometry |
| Experience | 31 Years |
| Location | 581 Second St, Manchester, New Hampshire |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417940560 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 610 (New Hampshire) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Manchester Optometric, Pa | 1052498839 | 5 |
News Archive
Addressing government entitlement programs, including Medicare, are key to that effort. Meanwhile, GOP presidential hopeful Newt Gingrich offers his own plans for wringing savings from health care costs.
St. Jude Medical, Inc., a global medical device company and ZONARE Medical Systems, a leading provider of premium ultrasound systems, today announced they have entered into a development and marketing agreement. Under this agreement, the companies will combine the St. Jude Medical intracardiac echocardiography (ICE) catheter and the ZONARE z.one Convertible Ultrasound system technology, and co-market an ultrasound system for intracardiac (inside the heart) imaging.
The National Institutes of Health (NIH) has awarded researchers at Rice University and the Texas Heart® Institute (THI) a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging (MRI) up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged hearts.
While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson's disease (PD), the impact extends beyond these threats.
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.
› Verified 9 days ago
| Provider Name | Manchester Optometric, Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1821287020 PECOS PAC ID: 1052498839 Enrollment ID: O20080403000082 |
News Archive
Addressing government entitlement programs, including Medicare, are key to that effort. Meanwhile, GOP presidential hopeful Newt Gingrich offers his own plans for wringing savings from health care costs.
St. Jude Medical, Inc., a global medical device company and ZONARE Medical Systems, a leading provider of premium ultrasound systems, today announced they have entered into a development and marketing agreement. Under this agreement, the companies will combine the St. Jude Medical intracardiac echocardiography (ICE) catheter and the ZONARE z.one Convertible Ultrasound system technology, and co-market an ultrasound system for intracardiac (inside the heart) imaging.
The National Institutes of Health (NIH) has awarded researchers at Rice University and the Texas Heart® Institute (THI) a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging (MRI) up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged hearts.
While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson's disease (PD), the impact extends beyond these threats.
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Randy Michael Williams, OD 581 Second St, Manchester, NH 03102-5200 Ph: (603) 668-2010 | Randy Michael Williams, OD 581 Second St, Manchester, NH 03102-5200 Ph: (603) 668-2010 |
News Archive
Addressing government entitlement programs, including Medicare, are key to that effort. Meanwhile, GOP presidential hopeful Newt Gingrich offers his own plans for wringing savings from health care costs.
St. Jude Medical, Inc., a global medical device company and ZONARE Medical Systems, a leading provider of premium ultrasound systems, today announced they have entered into a development and marketing agreement. Under this agreement, the companies will combine the St. Jude Medical intracardiac echocardiography (ICE) catheter and the ZONARE z.one Convertible Ultrasound system technology, and co-market an ultrasound system for intracardiac (inside the heart) imaging.
The National Institutes of Health (NIH) has awarded researchers at Rice University and the Texas Heart® Institute (THI) a $1 million Challenge Grant to refine cell-tracking nanotube technology that could make magnetic resonance imaging (MRI) up to 40 times more sensitive than existing MRIs and help guide adult stem cells within the human body to repair damaged hearts.
While much attention has focused on the potential for severe respiratory complications and unfavorable outcomes from the COVID-19 pandemic among patients with Parkinson's disease (PD), the impact extends beyond these threats.
Cappella, Inc., a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the start of Sideguard 3, an IVUS/OCT evaluation of the Sideguard® Coronary Sidebranch Stent & Delivery System. This is a European multicenter study to evaluate the vascular response to Sideguard in de novo bifurcation lesions of native coronary arteries.
› Verified 9 days ago
Marguerite Cote Od Pa Optometrist Medicare: Medicare Enrolled Practice Location: 254 Beech St, Manchester, NH 03103 Phone: 603-669-2043 Fax: 603-623-1686 | |
Dr. Alison Loranger, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 764 2nd St, Manchester, NH 03102 Phone: 603-669-3925 Fax: 603-669-0380 | |
Michael Meegan, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 581 2nd St Ste M, Manchester, NH 03102 Phone: 603-668-2010 | |
Dr. Guy Lessard, O,D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 345 S Willow St, Manchester, NH 03103 Phone: 603-625-1774 Fax: 603-624-1530 | |
Dr. Anthony Fusco & Associates Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6 March Ave, Manchester, NH 03103 Phone: 603-647-8247 Fax: 603-898-1534 | |
Dr. Michael Brian Nolen, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1500 S Willow St, Sears Optical, Manchester, NH 03103 Phone: 603-624-8363 Fax: 603-628-5266 | |
Dr. Denis Roger Allard, OD Optometrist Medicare: Medicare Enrolled Practice Location: 25 Bay St, Manchester, NH 03104 Phone: 603-622-1731 Fax: 603-668-3843 |